3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Breast
20
Other
2
Other neoplasm
1
Gynecologic
1
Endocrine
1
Conditions
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Surveys and Questionnaires
8
Blood Specimen Collection
7
lutetium Lu 177 dotatate
6
Surgical Procedures, Operative
6
Magnetic Resonance Spectroscopy
6
Adrenalectomy
5
Observation
4
Transurethral Resection of Prostate
3
Thyroidectomy
3
Positron-Emission Tomography
3
Lymph Node Excision
3
Data Collection
3
telotristat ethyl
2
surufatinib
2
gallium Ga 68 dotatate
2
Somatostatin
2
Radionuclide Imaging
2
Radiofrequency Ablation
2
Everolimus
2
Drug Therapy
2
Biopsy
2
somapacitan
1
methyl hydroxyethyl cellulose
1
lanreotide
1
fluorodopa F 18
1
exemestane
1
delta 24-sterol reductase
1
copper dotatate CU-64
1
Whole Body Imaging
1
Walking
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Tamoxifen
×
Endocrine
×
Clear all
NCT02753686
2023-02-15
Treat ER+ight
Novartis
Completed
440 enrolled